Antibacterial resistance leadership group (arlg)

Active Cooperative Agreement Awarded Last action

Award ID
UM1AI104681
Recipient
Awarding agency
Obligated
$420,075,953

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 99% complete
Originally
Funding
  • $385,690,440.21 Federal
  • $34,385,513.00 Non-federal
Place of performance
Durham, NC 27710, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $14,260,130
Amendment $14,260,130
Amendment $0
Amendment $0
Amendment $14,396,446
Amendment $1,451,944
Amendment $1,451,944
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $13,067,488
Amendment $13,067,488
Amendment $13,067,488
Amendment $13,067,488
Amendment $13,067,488
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment Antibacterial resistance leadership group (arlg) - our goal is to continue to advance the successful, multidisciplinary research agenda of the antibacterial… -$2,875
Amendment Antibacterial resistance leadership group (arlg) - description (provided by applicant): our goal is to create and implement an antibacterial resistance… -$21,160
Amendment -$2,875
Amendment Antibacterial resistance leadership group (arlg) - our goal is to continue to advance the successful, multidisciplinary research agenda of the antibacterial… -$2,875
Amendment Antibacterial resistance leadership group (arlg) - description (provided by applicant): our goal is to create and implement an antibacterial resistance… -$2,875
Amendment -$21,160
Amendment -$21,160
Amendment -$21,160
Amendment -$21,160
Amendment -$21,160
Amendment -$2,875
Amendment -$21,160
Amendment -$2,875
Amendment -$2,875
Amendment Antibacterial resistance leadership group (arlg) - our goal is to continue to advance the successful, multidisciplinary research agenda of the antibacterial… $14,675,641
Amendment Antibacterial resistance leadership group (arlg) - description (provided by applicant): our goal is to create and implement an antibacterial resistance… $14,675,641
Amendment $14,675,641
Amendment Antibacterial resistance leadership group (arlg) - our goal is to continue to advance the successful, multidisciplinary research agenda of the antibacterial… $14,675,641
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Dr. Van Tyne’s lab will receive de-identified Pseudomonas aeruginosa bacterial isolates collected from PHAGE study participants, extract genomic DNA from… $165,257
Vanderbilt University Medical Center Dr. Banerjee will serve as a Scientific Expert in Pediatrics of the Scientific Leadership Core, will serve a two-year term, will be a voting member of the… $299,199
The Children's Hospital Of Philadelphia Dcri #7668 ARLG2 parent $98,347
HMH Hospitals Corporation In Dr. Kreiswirth role, he will provide skilled laboratory support and expertise for the execution of bacterial biorepository assets managed by the ARLG.… $2,586,221
The Trustees Of The University Of Pennsylvania Dr. Lautenbach will serve as the Innovations Investigator focusing on Strategy Trial Design in Diagnostics of the Scientific Leadership Core, will serve a… $312,211
University Of Maryland, Baltimore Dr. Harris will serve as an Associate Director of the SLC. He will head up the Mentoring Committee. He will also be Vice-Chair of the Executive Committee. He… $688,722
Weill Medical College Of Cornell University Dcri #8673 ARLG2 oversight and administration $910,883
Mayo Clinic Dr. Patel will serve as the Director of the Laboratory Center. She will be a voting member of both the Executive and the Steering Committees of the ARLG. As the… $3,229,710
The Johns Hopkins University Dr. Cosgrove will serve as the Innovations Investigator focusing on Strategy Trial Design in Gram Positive of the Scientific Leadership Core. She will serve a… $243,405
Regents Of The University Of Minnesota Dr. Pettigrew will serve as an Associate Director of the Scientific Leadership Core, focusing on Diversity for the Antibacterial Resistance Leadership Group… $136,089
Midwestern University Dr. Marc Scheetz, from Midwestern University will serve as the Co-Investigator for the Antibacterial Resistance Leadership Group’s (ARLG) OPTIMIZE study.… $109,476
The Regents Of The University Of California. San Francisco Dr. Doernberg will serve as a Co-Investigator on the Clinical Operations Core. She will oversee the COC Protocol Teams assigned to finalize the protocols and… $742,339
Emory University Dr. Woodworth is an Infectious Disease physician scientist whose research applies metagenomic approaches to better understand colonization with multi-drug… $53,833
Tufts Medical Center Parent, Inc. Dr. Boucher will serve as Lead Investigator of the Scientific Leadership Core, will serve a two-year term, will be a voting member of both the Antibacterial… $328,638
Emory University Jessica Howard-Anderson, MD, MSc, will serve as a Co-Investigator on the "ARLG Innovations Working Group" project. In this role, Dr. Howard-Anderson will lead… $110,262
University Of North Carolina At Chapel Hill ARLG COC leadership – Dr. David van Duin will continue to work within the ARLG as the Associate Director of the COC, overseeing Multi-Drug Resistant… $667,320
University Of Southern California Jeffrey Klausner at University of Southern California will serve as the Co-Investigator for the ARLG MASTERMIND RING study under this subaward from the ARLG,… $203,198
Albany College Of Pharmacy And Health Sciences Dr. Lodise will serve as a Scientific Expert in Pharmacokinetics of the Scientific Leadership Core, will serve a two-year term, will be a voting member of the… $721,746
University Of Pittsburgh - Of The Commonwealth System Of Higher Education Dr. Doi will serve as a Chair of the Gram Negative Subcommittee of the Scientific Leadership Core, will serve a two-year term, will be a voting member of the… $203,137
University Of Utah Dr. Hanson will serve as a Chair of the Diagnostics Subcommittee of the Scientific Leadership Core, will serve a two-year term, will be a voting member of the… $301,162
The Regents Of The University Of California. San Francisco Dr. Chambers and Dr. Fowler (contact) will be PI/PD of the ARLG. Steering Committee and Dr. Fowler will be the Chair of the ARLG Executive Committee. Dr.… $937,791
George Washington University (The) Studies of antibacterial resistance (AR) pose diverse scientific and operational challenges. Studies vary widely in design (e.g., objectives, endpoints, and… $12,264,244
The Regents Of The University Of California. San Francisco Dr. Chiu will assist the execution of all aspects of this study, including specimen receipt and accessioning, preparation of sequencing libraries, and… $152,917
Mayo Clinic Dcri #8477 ARLG2 parent oversight and administration $44,811
Emory University The main objective of this award is to rigorously evaluate evidence for the association between US patients’ risk of community-associated… $100,376
The Johns Hopkins University Dcri #8477 ARLG2 parent oversight and administration $53,256
The Johns Hopkins University In partnership with Dr. Schooley, Dr Pranita will serve as the PI for Phage as a Trialist in Training. As the PI for Phage, she will be assisting Dr. Schooley… $549,183
The Regents Of The University Of California. San Francisco To goal of this project is to utilize transcriptomic sequencing to better understand and diagnose lower respiratory tract infections in lung transplant… $82,000
Vanderbilt University Medical Center Banerjee, Ritu, M.D., Ph.D., Principal Investigator (Pediatric Infectious Diseases � 0.1 FTE, 4 years). Dr. Banerjee will be responsible for completing… $247,250
Brigham & Womens Hospital Inc. The aims of this research are as follows: Aim 1) Fully optimize a SHERLOCK-based assay for the detection of bacterial infections and resistance patterns. Aim 2)… $282,907
University Of California, San Diego David Pride's lab at UCSD will perform the following deliverables for the Antibacterial Resistance Leadership Group ("ARLG") to support protocol 20-0001, A… $786,304
The Univeristy Of Texas M.d. Anderson Cancer Center Dr. Shelburne will serve as a Scientific Expert Immunocompromised Host in of the Scientific Leadership Core, will serve a two-year term, will be a voting member… $253,728
Weill Medical College Of Cornell University Dr. Satlin will serve as Co-Investigator on the Clinical Operations Core (COC). He will oversee the COC Protocol Teams assigned to finalize the protocols and… $730,793
Northwestern University Dr. Hareza will be responsible for conducting RNA expression analysis, analyzing data, preparing manuscripts for publication and presenting findings at national… $150,793
University Of California, LOS Angeles Dr. Torres will be responsible for all study operations. Specifically, he will 1) oversee set up, recruitment and data collection activities at all sites, 2)… $78,750
The Regents Of The University Of California. San Francisco Dr. Langelier and his laboratory will be responsible for overseeing metagenomic and transcriptomic analyses of 200 lower respiratory samples collected for… $144,132
The Johns Hopkins University The Johns Hopkins University School of Medicine (JHUSOM) will serve under a subaward as an index testing laboratory for the Antibacterial Resistance… $98,079
University Of North Carolina At Chapel Hill Dr. Mackow will be responsible for all proposed data collection and analyses. She will have 80% protected time during the year for research responsibilities and… $258,827
The Johns Hopkins University Dr. Hareza will be responsible for collecting data, conducting whole genome sequencing, analyzing data, preparing manuscripts for publication and presenting… $166,177
University Of North Carolina At Chapel Hill RENCI will provide software development services to support the GENO-SMART application. The RENCI developers will participate in relevant project meetings,… $72,038
Emory University The objectives of this research are as follows: Objective 1: Use a metagenomic approach to estimate long-term engraftment dynamics of donor taxa in PREMIX… $349,898
The University Of Queensland Prof. David Paterson will serve as the Innovations Investigator focusing on Strategy Trial Design in Gram Negative of the Scientific Leadership Core, will be… $40,954
Case Western Reserve University Dr. Bonomo will work with ARLG staff and investigators to transfer ARLG-related isolates ( e.g., MDRO, CRACKLE II) and their linked/associated data ( e.g.,… $206,500
Case Western Reserve University The objectives of this research are as follows: 1} To biochemically characterize the hydrolysis of tebipenem by clinically relevant carbapenemases, as well as… $63,000
University Of California, San Diego Banerjee, Ritu, M.D., Ph.D., Principal Investigator (Pediatric Infectious Diseases – 0.1 FTE, 4 years). Dr. Banerjee will be responsible for completing… $192,766
University Of California, San Diego In collaboration with the Antibacterial Resistance Leadership Group, Dr. Conrad will participate in study team meetings, assist with developing the study… $103,911
The University Of Queensland Prof. David Paterson will serve as the Innovations Investigator focusing on Strategy Trial Design in Gram Negative of the Scientific Leadership Core, will serve… $52,898
University Of Texas Health Science Center At Houston The innovative vision of GENO-SMART seeks to incorporate established and cutting-edge sequencing technologies, including long-read and metagenomics platforms,… $111,412
University Of Texas Health Science Center At Houston $390,633
Weill Medical College Of Cornell University Dr. Satlin will serve as the PI for this protocol. He will be responsible for all aspects of the study, including but not limited to monitoring and querying the… $327,706
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award UM1AI104681?

UM1AI104681 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2013.

How much is award UM1AI104681 worth?

$420,075,953 has been obligated on UM1AI104681: $385,690,440 in federal funding and $34,385,513 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login